Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Comput Methods Programs Biomed Update ; 3: 100095, 2023.
Article in English | MEDLINE | ID: covidwho-2248311

ABSTRACT

Background: The rates of mental health disorders such as anxiety and depression are at an all-time high especially since the onset of COVID-19, and the need for readily available digital health care solutions has never been greater. Wearable devices have increasingly incorporated sensors that were previously reserved for hospital settings. The availability of wearable device features that address anxiety and depression is still in its infancy, but consumers will soon have the potential to self-monitor moods and behaviors using everyday commercially-available devices. Objective: This study aims to explore the features of wearable devices that can be used for monitoring anxiety and depression. Methods: Six bibliographic databases, including MEDLINE, EMBASE, PsycINFO, IEEE Xplore, ACM Digital Library, and Google Scholar were used as search engines for this review. Two independent reviewers performed study selection and data extraction, while two other reviewers justified the cross-checking of extracted data. A narrative approach for synthesizing the data was utilized. Results: From 2408 initial results, 58 studies were assessed and highlighted according to our inclusion criteria. Wrist-worn devices were identified in the bulk of our studies (n = 42 or 71%). For the identification of anxiety and depression, we reported 26 methods for assessing mood, with the State-Trait Anxiety Inventory being the joint most common along with the Diagnostic and Statistical Manual of Mental Disorders (n = 8 or 14%). Finally, n = 26 or 46% of studies highlighted the smartphone as a wearable device host device. Conclusion: The emergence of affordable, consumer-grade biosensors offers the potential for new approaches to support mental health therapies for illnesses such as anxiety and depression. We believe that purposefully-designed wearable devices that combine the expertise of technologists and clinical experts can play a key role in self-care monitoring and diagnosis.

2.
Journal of Consumer Health on the Internet ; 26(4):337-356, 2022.
Article in English | ProQuest Central | ID: covidwho-2160685

ABSTRACT

Objective: This study aimed to categorize and analyze the public response toward third/booster shots of COVID-19 on Twitter. Methods: We downloaded the COVID-19 vaccine booster shots related Tweets using the Twitter API. The collected Tweets were pre-processed to prepare them for analysis by (1) removing non-English language tweets, retweets, emojis, emoticons, non-printable characters, the punctuation marks, and the prepositions, (2) anonymizing the identity of the users, and (3) normalizing various forms of the same words. We used the state-of-the-art BertTopic modeling library to identify the most popular topics. Results: Of 165,048 Tweets collected, 36,908 Tweets were analyzed in this study. From these tweets, we identified 9 topics, which were about Biden administration, Pfizer & BioNTech, Moderna, Johnson & Johnson, eligibility for booster shots, side effects, Donald Trump, variants of the Novel Coronavirus, and conspiracy theory & propaganda. The mean of sentiment was positive in all topics. The lowest and highest mean of sentiments were for the Donald Trump topic (0.0097) and the Johnson & Johnson topic (0.1294), respectively. Conclusions: The topics identified in this study not only accurately reflect the contemporary COVID-19 discussion, but also the high degree of politicization in the USA. While the latter might be a result of our rejection of non-English tweets, it is reassuring to see our fully automated, unsupervised pipeline reliably extract such global features in the data at scale. We, therefore, believe that the methodology presented in this study is mature and useful for other infoveillance studies on a wide variety of topics.

4.
QScience Connect ; 2022(3):1-2, 2022.
Article in English | Academic Search Complete | ID: covidwho-2025135

ABSTRACT

Engaging in the arts has been demonstrated scientifically to enhance brain function. Creativity can modify a person's perspective and experience of the world. Changes in cerebrum waves impact changes in the nervous system which can raise serotonin levels. This can affect emotions positively by regulating moods and improving brain function which influences both psychological and physiological wellbeing. Creativity is part of our natural development and should be a part of our healing as a community. Art Therapy (AT) is a mental health profession which carries out innovative adaptations as it is recognized as a stand-alone clinical intervention and through community engagement and social justice. Art Therapists are collaborating within diverse fields of clinical and non-clinical practice such as neuroscience and virtual reality. Three papers explore the development of Art Therapy as a profession in Qatar and how AT is an accessible and underutilised or often misjudged profession. Paper one introduces ways that AT is practiced as a clinical, social action and community-based profession. AT might address the shame connected with psychological wellness by connecting with communities, sharing experiences of AT with the general public and by clinical professionals to support their careers, prompting less burnout. Dr. Hadi Mohamad Abu Rasheed shares the Qatar Cancer Society's experience of using Art in psychosocial support for children living with cancer. The western trained Art Therapist's awareness of cultural competence when working in the context of non-western cultural approaches to mental health is imperative to complement the heritage, creativity and community values of the local culture. Intersectional frameworks will inform ethical professional values to be upheld. Paper two develops how AT offers context to reduce the stigma of mental health in Qatar. The first Museum and Gallery AT visit in Qatar, with patients attending a substance misuse program, saw outcomes that included increased engagement in clinical sessions and an art exhibition that was held in the hospital and at conferences within Qatar and globally. Paper three discusses the global alterations in the AT workplace following the Covid-19 epidemic;online AT;and how AT has adapted to employing technology before and after the pandemic. The technology employed in AT is not new. Art Therapists are now using Virtual Reality, where the client becomes part of the world they have created, interacting in it, with the art therapist present. The Emotion Sensing Recognition (ESRA) app is being developed by Dr. Mowafa and Dr. Jens with the consultation of an Art Therapist Trish, to ensure the ethics of working with images. This app can increase positive parent-child attachment and increase the ability to recognise and talk about feelings for parent and child. AT is a cost-effective adaptive treatment and is being prescribed by General Practitioners in the UK and USA alongside visits to museums, choirs etc. How will Qatar embrace this adaptable, unique profession and will ensure it is ethically practiced by trained licensed Art Therapists? Collaborative research and training within different fields should be encouraged. [ FROM AUTHOR] Copyright of QScience Connect is the property of Hamad bin Khalifa University Press (HBKU Press) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

5.
Comput Methods Programs Biomed Update ; 2: 100066, 2022.
Article in English | MEDLINE | ID: covidwho-2007620

ABSTRACT

Despite improvement in detection rates, the prevalence of mental health disorders such as anxiety and depression are on the rise especially since the outbreak of the COVID-19 pandemic. Symptoms of mental health disorders have been noted and observed on social media forums such Facebook. We explored machine learning models used to detect anxiety and depression through social media. Six bibliographic databases were searched for conducting the review following PRISMA-ScR protocol. We included 54 of 2219 retrieved studies. Users suffering from anxiety or depression were identified in the reviewed studies by screening their online presence and their sharing of diagnosis by patterns in their language and online activity. Majority of the studies (70%, 38/54) were conducted at the peak of the COVID-19 pandemic (2019-2020). The studies made use of social media data from a variety of different platforms to develop predictive models for the detection of depression or anxiety. These included Twitter, Facebook, Instagram, Reddit, Sina Weibo, and a combination of different social sites posts. We report the most common Machine Learning models identified. Identification of those suffering from anxiety and depression disorders may be achieved using prediction models to detect user's language on social media and has the potential to complimenting traditional screening. Such analysis could also provide insights into the mental health of the public especially so when access to health professionals can be restricted due to lockdowns and temporary closure of services such as we saw during the peak of the COVID-19 pandemic.

6.
Stud Health Technol Inform ; 290: 704-708, 2022 Jun 06.
Article in English | MEDLINE | ID: covidwho-1933573

ABSTRACT

This study aims to find out the variation of Twitter users' sentiment before and after the COVID-19 vaccine rollout. We analyzed all COVID-19 related tweets posted on Twitter within two timeframes: September 2020 (T1) and March 2021 (T2). A total of 3 million tweets from over 132 thousand users were analyzed. We then categorized the users into two groups whose overall sentiment shifted positively or negatively from T1 to T2. Our analysis showed that 27% of users' sentiment shifted from T1 to T2 positively and the users were more confident about vaccine safety and efficacy. Users reported positive sentiments about travelling and the easing of lockdown measures. Also, 20.4% of the users' sentiment shifted negatively from T1 to T2. This group of Twitter users were more concerned about the adverse side effects of the vaccine, the pace of vaccine development as well as the emerging novel coronavirus variants. Interestingly, over half of the users' overall sentiment remained the same in both periods of T1 and T2, indicating indifference about vaccine rollout. We believe that our analysis will support the exploration of public reaction to COVID-19 vaccine rollout and assess policy makers' decision to combat the pandemic.


Subject(s)
COVID-19 Vaccines , COVID-19 , Drug-Related Side Effects and Adverse Reactions , Social Media , Attitude , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Communicable Disease Control , Humans , Vaccines
7.
Stud Health Technol Inform ; 295: 366-369, 2022 Jun 29.
Article in English | MEDLINE | ID: covidwho-1924038

ABSTRACT

In this study, we addressed the alternative medications that have been targeted in the clinical trials (CTs) to be evidenced as an adjuvant treatment against COVID-19. Based on the outcomes from CTs, we found that dietary supplements such as Lactoferrin, and Probiotics (as SivoMixx) can play a role enhancing the immunity thus can be used as prophylactics against COVID-19 infection. Vitamin D was proven as an effective adjuvant treatment against COVID-19, while Vitamin C role is uncertain and needs more investigation. Herbals such as Guduchi Ghan Vati can be used as prophylactic, while Resveratrol can be used to reduce the hospitalization risk of COVID-19 patients. On the contrary, there were no clinical improvements demonstrated when using Cannabidiol. This study is a part of a two-phase research study. In the first phase, we gathered evidence-based information on alternative therapeutics for COVID-19 that are under CT. In the second phase, we plan to build a mobile health application that will provide evidence based alternative therapy information to health consumers.


Subject(s)
COVID-19 Drug Treatment , Complementary Therapies , Ascorbic Acid , Clinical Trials as Topic , Dietary Supplements , Humans , Phytotherapy , Resveratrol/therapeutic use , SARS-CoV-2 , Vitamin D/therapeutic use
8.
Stud Health Technol Inform ; 295: 201-204, 2022 Jun 29.
Article in English | MEDLINE | ID: covidwho-1924027

ABSTRACT

The recent advancements in artificial intelligence (AI) and the Internet of Medical Things (IoMT) have opened new horizons for healthcare technology. AI models, however, rely on large data that must be shared with the centralized entity developing the model. Data sharing leads to privacy preservation and legal issues. Federated Learning (FL) enables the training of AI models on distributed data. Hence, a large amount of IoMT data can be put into use without the need for sharing the data. This paper presents the opportunities offered by FL for privacy preservation in IoMT data. With FL, the complicated dynamics and agreements for data-sharing can be avoided. Furthermore, it describes the use cases of FL in facilitating collaborative efforts to develop AI for COVID-19 diagnosis. Since handling data from multiple sites poses its challenges, the paper also highlights the critical challenges associated with FL developments for IoMT data. Addressing these challenges will lead to gaining maximum benefit from data-driven AI technologies in IoMT.


Subject(s)
COVID-19 , Internet of Things , Artificial Intelligence , COVID-19 Testing , Humans , Privacy
9.
JMIR Form Res ; 6(5): e36238, 2022 May 11.
Article in English | MEDLINE | ID: covidwho-1779877

ABSTRACT

BACKGROUND: Contact tracing has been globally adopted in the fight to control the infection rate of COVID-19. To this aim, several mobile apps have been developed. However, there are ever-growing concerns over the working mechanism and performance of these applications. The literature already provides some interesting exploratory studies on the community's response to the applications by analyzing information from different sources, such as news and users' reviews of the applications. However, to the best of our knowledge, there is no existing solution that automatically analyzes users' reviews and extracts the evoked sentiments. We believe such solutions combined with a user-friendly interface can be used as a rapid surveillance tool to monitor how effective an application is and to make immediate changes without going through an intense participatory design method. OBJECTIVE: In this paper, we aim to analyze the efficacy of AI and NLP techniques for automatically extracting and classifying the polarity of users' sentiments by proposing a sentiment analysis framework to automatically analyze users' reviews on COVID-19 contact tracing mobile apps. We also aim to provide a large-scale annotated benchmark data set to facilitate future research in the domain. As a proof of concept, we also developed a web application based on the proposed solutions, which is expected to help the community quickly analyze the potential of an application in the domain. METHODS: We propose a pipeline starting from manual annotation via a crowd-sourcing study and concluding with the development and training of artificial intelligence (AI) models for automatic sentiment analysis of users' reviews. In detail, we collected and annotated a large-scale data set of user reviews on COVID-19 contact tracing applications. We used both classical and deep learning methods for classification experiments. RESULTS: We used 8 different methods on 3 different tasks, achieving up to an average F1 score of 94.8%, indicating the feasibility of the proposed solution. The crowd-sourcing activity resulted in a large-scale benchmark data set composed of 34,534 manually annotated reviews. CONCLUSIONS: The existing literature mostly relies on the manual or exploratory analysis of users' reviews on applications, which is tedious and time-consuming. In existing studies, generally, data from fewer applications are analyzed. In this work, we showed that AI and natural language processing techniques provide good results for analyzing and classifying users' sentiments' polarity and that automatic sentiment analysis can help to analyze users' responses more accurately and quickly. We also provided a large-scale benchmark data set. We believe the presented analysis, data set, and proposed solutions combined with a user-friendly interface can be used as a rapid surveillance tool to analyze and monitor mobile apps deployed in emergency situations leading to rapid changes in the applications without going through an intense participatory design method.

10.
Stud Health Technol Inform ; 289: 57-60, 2022 Jan 14.
Article in English | MEDLINE | ID: covidwho-1643431

ABSTRACT

Public perception about vaccines is imperative for successful vaccination programs. This study aims to measure the shift of sentiment towards vaccines after the COVID-19 outbreak in the Arab-speaking population. The study used vaccine-related Arabic Tweets and analyzed the sentiment of users in two different time frames, before 2020 (T1) and after 2020 (T2). The analysis showed that in T1, 48.05% of tweets were positive, and 16.47% of tweets were negative. In T2, 43.03% of tweets were positive, and 20.56% of tweets were negative. Among the Twitter users, the sentiment of 15.92% users shifted towards positive, and the sentiment of 17.90% users shifted towards negative. Public sentiment that have shifted towards positive may be due to the hope of vaccine efficacy, whereas public sentiment that have shifted towards negative may be due to the concerns related to vaccine side effects and misinformation. This study can support policymakers in the Arab world to combat the COVID-19 pandemic by utilizing tools to understand public opinion and sentiment.


Subject(s)
COVID-19 , Social Media , Arab World , Attitude , Humans , Pandemics , SARS-CoV-2 , Vaccination , Vaccine Efficacy
11.
Stud Health Technol Inform ; 289: 9-13, 2022 Jan 14.
Article in English | MEDLINE | ID: covidwho-1643430

ABSTRACT

Tremendous changes have been witnessed in the post-COVID-19 world. Global efforts were initiated to reach a successful treatment for this emerging disease. These efforts have focused on developing vaccinations and/or finding therapeutic agents that can be used to combat the virus or reduce its accompanying symptoms. Gulf Cooperation Council (GCC) countries have initiated efforts on many clinical trials to address the efficacy and the safety of several therapeutic agents used for COVID-19 treatment. In this article, we provide an overview of the GCC's clinical trials and associated drugs' discovery process in the pursuit of an effective medication for COVID-19.


Subject(s)
COVID-19 Drug Treatment , Drug Discovery , Clinical Trials as Topic , Humans
12.
J Med Internet Res ; 23(9): e29136, 2021 09 14.
Article in English | MEDLINE | ID: covidwho-1406794

ABSTRACT

BACKGROUND: Technologies have been extensively implemented to provide health care services for all types of clinical conditions during the COVID-19 pandemic. While several reviews have been conducted regarding technologies used during the COVID-19 pandemic, they were limited by focusing either on a specific technology (or features) or proposed rather than implemented technologies. OBJECTIVE: This review aims to provide an overview of technologies, as reported in the literature, implemented during the first wave of the COVID-19 pandemic. METHODS: We conducted a scoping review using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) Extension for Scoping Reviews. Studies were retrieved by searching 8 electronic databases, checking the reference lists of included studies and relevant reviews (backward reference list checking), and checking studies that cited included studies (forward reference list checking). The search terms were chosen based on the target intervention (ie, technologies) and the target disease (ie, COVID-19). We included English publications that focused on technologies or digital tools implemented during the COVID-19 pandemic to provide health-related services regardless of target health condition, user, or setting. Two reviewers independently assessed the eligibility of studies and extracted data from eligible papers. We used a narrative approach to synthesize extracted data. RESULTS: Of 7374 retrieved papers, 126 were deemed eligible. Telemedicine was the most common type of technology (107/126, 84.9%) implemented in the first wave of the COVID-19 pandemic, and the most common mode of telemedicine was synchronous (100/108, 92.6%). The most common purpose of the technologies was providing consultation (75/126, 59.5%), followed by following up with patients (45/126, 35.7%), and monitoring their health status (22/126, 17.4%). Zoom (22/126, 17.5%) and WhatsApp (12/126, 9.5%) were the most commonly used videoconferencing and social media platforms, respectively. Both health care professionals and health consumers were the most common target users (103/126, 81.7%). The health condition most frequently targeted was COVID-19 (38/126, 30.2%), followed by any physical health conditions (21/126, 16.7%), and mental health conditions (13/126, 10.3%). Technologies were web-based in 84.1% of the studies (106/126). Technologies could be used through 11 modes, and the most common were mobile apps (86/126, 68.3%), desktop apps (73/126, 57.9%), telephone calls (49/126, 38.9%), and websites (45/126, 35.7%). CONCLUSIONS: Technologies played a crucial role in mitigating the challenges faced during the COVID-19 pandemic. We did not find papers describing the implementation of other technologies (eg, contact-tracing apps, drones, blockchain) during the first wave. Furthermore, technologies in this review were used for other purposes (eg, drugs and vaccines discovery, social distancing, and immunity passport). Future research on studies on these technologies and purposes is recommended, and further reviews are required to investigate technologies implemented in subsequent waves of the pandemic.


Subject(s)
COVID-19 , Telemedicine , Humans , Pandemics , SARS-CoV-2 , Technology
13.
Comput Methods Programs Biomed Update ; 1: 100025, 2021.
Article in English | MEDLINE | ID: covidwho-1330711

ABSTRACT

BACKGROUND: Since the onset of the COVID-19 pandemic, the world witnessed disruption on an unprecedented scale affecting our daily lives including but not limited to healthcare, business, education, and transportation. Deep Learning (DL) is a branch of Artificial intelligence (AI) applications, the recent growth of DL includes features that could be helpful in fighting the COVID-19 pandemic. Utilizing such features could support public health efforts. OBJECTIVE: Investigate the literature available in the use of DL technology to support dealing with the COVID-19 crisis. We summarize the literature that uses DL features to analyze datasets for the purpose of a quick COVID-19 detection. METHODS: This review follows PRISMA Extension for Scoping Reviews (PRISMA-ScR). We have scanned the most two commonly used databases (IEEE, ACM). Search terms were identified based on the target intervention (DL) and the target population (COVID-19). Two authors independently handled study selection and one author assigned for data extraction. A narrative approach is used to synthesize the extracted data. RESULTS: We retrieved 53 studies and after passing through PRISMA excluding criteria, only 17 studies are considered in this review. All studies used deep learning for detection of COVID-19 cases in early stage based on different diagnostic modalities. Convolutional Neural Network (CNN) and Transfer Learning (TL) were the most commonly used techniques. CONCLUSION: The included studies showed that DL techniques has significant impact on early detection of COVID-19 with high accuracy rate. However, most of the proposed methods are still in development and not tested in a clinical setting. Further investigation and collaboration are required from the research community and healthcare professionals in order to develop and standardize guidelines for use of DL in the healthcare domain.

14.
Computer Methods and Programs in Biomedicine Update ; : 100012, 2021.
Article in English | ScienceDirect | ID: covidwho-1213106

ABSTRACT

Background Anxiety and depression rates are at an all-time high. Smartphone-based mental health chatbots can aid psychiatrists replacing some of the costly human based interaction providing a unique opportunity to expand the availability and quality of mental health intervention whilst providing an alternative approach to fill the much-needed self-care gap. Objective Assess the quality and characteristics of chatbots for anxiety and depression available on Android and iOS systems. Methods A search was performed in the App Store and Google Play Store following the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) protocol to identify existing chatbot apps for anxiety and depression. Eligibility was assessed by two individuals based on predefined eligibility criteria. Meta-data of the included chatbots and their characteristics were extracted from their description and post-installation by two reviewers. Information on quality was assessed by following the mHONcode principles. Results Only a handful (n=11) of chatbots were included from an initial search of 1000 that provide a substitute for human-human based interaction and clearly had a therapeutic human substitute goal in mind. The majority of reviewed apps had a high number of downloads indicating their popularity. The apps were also of a general high quality based on our assessment according to the mHONcode principles. Conclusion The general popularity of apps reviewed, and results of our quality assessment indicate chatbots have a promising future within the realm of anxiety and depression. Anxiety and depression chatbot apps have the potential to increase the capacity of mental health self-care providing much needed low-cost assistance to professionals.

15.
J Med Internet Res ; 23(3): e23703, 2021 03 08.
Article in English | MEDLINE | ID: covidwho-1088869

ABSTRACT

BACKGROUND: Shortly after the emergence of COVID-19, researchers rapidly mobilized to study numerous aspects of the disease such as its evolution, clinical manifestations, effects, treatments, and vaccinations. This led to a rapid increase in the number of COVID-19-related publications. Identifying trends and areas of interest using traditional review methods (eg, scoping and systematic reviews) for such a large domain area is challenging. OBJECTIVE: We aimed to conduct an extensive bibliometric analysis to provide a comprehensive overview of the COVID-19 literature. METHODS: We used the COVID-19 Open Research Dataset (CORD-19) that consists of a large number of research articles related to all coronaviruses. We used a machine learning-based method to analyze the most relevant COVID-19-related articles and extracted the most prominent topics. Specifically, we used a clustering algorithm to group published articles based on the similarity of their abstracts to identify research hotspots and current research directions. We have made our software accessible to the community via GitHub. RESULTS: Of the 196,630 publications retrieved from the database, we included 28,904 in our analysis. The mean number of weekly publications was 990 (SD 789.3). The country that published the highest number of COVID-19-related articles was China (2950/17,270, 17.08%). The highest number of articles were published in bioRxiv. Lei Liu affiliated with the Southern University of Science and Technology in China published the highest number of articles (n=46). Based on titles and abstracts alone, we were able to identify 1515 surveys, 733 systematic reviews, 512 cohort studies, 480 meta-analyses, and 362 randomized control trials. We identified 19 different topics covered among the publications reviewed. The most dominant topic was public health response, followed by clinical care practices during the COVID-19 pandemic, clinical characteristics and risk factors, and epidemic models for its spread. CONCLUSIONS: We provide an overview of the COVID-19 literature and have identified current hotspots and research directions. Our findings can be useful for the research community to help prioritize research needs and recognize leading COVID-19 researchers, institutes, countries, and publishers. Our study shows that an AI-based bibliometric analysis has the potential to rapidly explore a large corpus of academic publications during a public health crisis. We believe that this work can be used to analyze other eHealth-related literature to help clinicians, administrators, and policy makers to obtain a holistic view of the literature and be able to categorize different topics of the existing research for further analyses. It can be further scaled (for instance, in time) to clinical summary documentation. Publishers should avoid noise in the data by developing a way to trace the evolution of individual publications and unique authors.


Subject(s)
Bibliometrics , COVID-19/epidemiology , Machine Learning , COVID-19/virology , Humans , Research Design , SARS-CoV-2/isolation & purification
16.
Comput Methods Programs Biomed Update ; 1: 100001, 2021.
Article in English | MEDLINE | ID: covidwho-973983

ABSTRACT

Background: As public health strategists and policymakers explore different approaches to lessen the devastating effects of novel coronavirus disease (COVID-19), blockchain technology has emerged as a resource that can be utilized in numerous ways. Many blockchain technologies have been proposed or implemented during the COVID-19 pandemic; however, to the best of our knowledge, no comprehensive reviews have been conducted to uncover and summarise the main feature of these technologies. Objective: This study aims to explore proposed or implemented blockchain technologies used to mitigate the COVID-19 challenges as reported in the literature. Methods: We conducted a scoping review in line with guidelines of PRISMA Extension for Scoping Reviews (PRISMA-ScR). To identify relevant studies, we searched 11 bibliographic databases (e.g., EMBASE and MEDLINE) and conducted backward and forward reference list checking of the included studies and relevant reviews. The study selection and data extraction were conducted by 2 reviewers independently. Data extracted from the included studies was narratively summarised and described. Results: 19 of 225 retrieved studies met eligibility criteria in this review. The included studies reported 10 used cases of blockchain to mitigate COVID-19 challenges; the most prominent use cases were contact tracing and immunity passports. While the blockchain technology was developed in 10 studies, its use was proposed in the remaining 9 studies. The public blockchain technology was the most commonly utilized type in the included studies. All together, 8 different consensus mechanisms were used in the included studies. Out of 10 studies that identified the used platform, 9 studies used Ethereum to run the blockchain. Solidity was the most prominent programming language used in developing blockchain technology in the included studies. The transaction cost was reported in only 4 of the included studies and varied between USD 10-10 and USD 5. The expected latency and expected scalability were not identified in the included studies. Conclusion: Blockchain technologies are expected to play an integral role in the fight against the COVID-19 pandemic. Many possible applications of blockchain were found in this review; however, most of them are not mature enough to reveal their expected impact in the fight against COVID-19. We encourage governments, health authorities, and policymakers to consider all blockchain applications suggested in the current review to combat COVID-19 challenges. There is a pressing need to empirically examine how effective blockchain technologies are in mitigating COVID-19 challenges. Further studies are required to assess the performance of blockchain technologies' fight against COVID-19 in terms of transaction cost, scalability, and/or latency when using different consensus algorithms, platforms, and access types.

17.
J Med Internet Res ; 22(12): e20756, 2020 12 15.
Article in English | MEDLINE | ID: covidwho-962391

ABSTRACT

BACKGROUND: In December 2019, COVID-19 broke out in Wuhan, China, leading to national and international disruptions in health care, business, education, transportation, and nearly every aspect of our daily lives. Artificial intelligence (AI) has been leveraged amid the COVID-19 pandemic; however, little is known about its use for supporting public health efforts. OBJECTIVE: This scoping review aims to explore how AI technology is being used during the COVID-19 pandemic, as reported in the literature. Thus, it is the first review that describes and summarizes features of the identified AI techniques and data sets used for their development and validation. METHODS: A scoping review was conducted following the guidelines of PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews). We searched the most commonly used electronic databases (eg, MEDLINE, EMBASE, and PsycInfo) between April 10 and 12, 2020. These terms were selected based on the target intervention (ie, AI) and the target disease (ie, COVID-19). Two reviewers independently conducted study selection and data extraction. A narrative approach was used to synthesize the extracted data. RESULTS: We considered 82 studies out of the 435 retrieved studies. The most common use of AI was diagnosing COVID-19 cases based on various indicators. AI was also employed in drug and vaccine discovery or repurposing and for assessing their safety. Further, the included studies used AI for forecasting the epidemic development of COVID-19 and predicting its potential hosts and reservoirs. Researchers used AI for patient outcome-related tasks such as assessing the severity of COVID-19, predicting mortality risk, its associated factors, and the length of hospital stay. AI was used for infodemiology to raise awareness to use water, sanitation, and hygiene. The most prominent AI technique used was convolutional neural network, followed by support vector machine. CONCLUSIONS: The included studies showed that AI has the potential to fight against COVID-19. However, many of the proposed methods are not yet clinically accepted. Thus, the most rewarding research will be on methods promising value beyond COVID-19. More efforts are needed for developing standardized reporting protocols or guidelines for studies on AI.


Subject(s)
Artificial Intelligence , COVID-19/epidemiology , COVID-19/therapy , COVID-19/virology , Humans , Pandemics , SARS-CoV-2/isolation & purification
18.
J Med Internet Res ; 22(4): e19016, 2020 04 21.
Article in English | MEDLINE | ID: covidwho-96777

ABSTRACT

BACKGROUND: The recent coronavirus disease (COVID-19) pandemic is taking a toll on the world's health care infrastructure as well as the social, economic, and psychological well-being of humanity. Individuals, organizations, and governments are using social media to communicate with each other on a number of issues relating to the COVID-19 pandemic. Not much is known about the topics being shared on social media platforms relating to COVID-19. Analyzing such information can help policy makers and health care organizations assess the needs of their stakeholders and address them appropriately. OBJECTIVE: This study aims to identify the main topics posted by Twitter users related to the COVID-19 pandemic. METHODS: Leveraging a set of tools (Twitter's search application programming interface (API), Tweepy Python library, and PostgreSQL database) and using a set of predefined search terms ("corona," "2019-nCov," and "COVID-19"), we extracted the text and metadata (number of likes and retweets, and user profile information including the number of followers) of public English language tweets from February 2, 2020, to March 15, 2020. We analyzed the collected tweets using word frequencies of single (unigrams) and double words (bigrams). We leveraged latent Dirichlet allocation for topic modeling to identify topics discussed in the tweets. We also performed sentiment analysis and extracted the mean number of retweets, likes, and followers for each topic and calculated the interaction rate per topic. RESULTS: Out of approximately 2.8 million tweets included, 167,073 unique tweets from 160,829 unique users met the inclusion criteria. Our analysis identified 12 topics, which were grouped into four main themes: origin of the virus; its sources; its impact on people, countries, and the economy; and ways of mitigating the risk of infection. The mean sentiment was positive for 10 topics and negative for 2 topics (deaths caused by COVID-19 and increased racism). The mean for tweet topics of account followers ranged from 2722 (increased racism) to 13,413 (economic losses). The highest mean of likes for the tweets was 15.4 (economic loss), while the lowest was 3.94 (travel bans and warnings). CONCLUSIONS: Public health crisis response activities on the ground and online are becoming increasingly simultaneous and intertwined. Social media provides an opportunity to directly communicate health information to the public. Health systems should work on building national and international disease detection and surveillance systems through monitoring social media. There is also a need for a more proactive and agile public health presence on social media to combat the spread of fake news.


Subject(s)
Coronavirus Infections/epidemiology , Data Mining , Health Communication , Pneumonia, Viral/epidemiology , Social Media , Betacoronavirus , COVID-19 , Coronavirus , Data Collection , Global Health , Humans , Pandemics , Public Health , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL